Eli Lilly and Co., US5324571083

Eli Lilly stock gains 11.4% in week through October 30

Published on 10/31/2026 at 10:07 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Eli Lilly stock ended Friday at 1,275.40 euros on Xetra. A Saturday Lang & Schwarz quote remained close to the latest exchange close.

Weekly momentum stays firmly positive

  • Eli Lilly shares posted a double-digit weekly gain through Friday, October 30.
  • The stock remained close to Friday's Xetra closing level in Saturday trading.
Eli Lilly and Co., US5324571083, Illustration mit AI erstellt.

Eli Lilly stock gained 11.43 percent between the Xetra close on Friday, October 23, and the close on Friday, October 30. Yahoo Finance listed the Xetra closing level at 1,275.40 euros on October 30, compared with 1,144.60 euros one week earlier.

The weekly advance puts the US pharmaceutical company among the stronger large-cap healthcare names in the period. The move provides a clear change in market positioning, although a weekly price gain alone does not establish a lasting shift in earnings expectations.

Saturday trading remains near Friday close

Eli Lilly stock traded at 1,267.10 euros on Lang & Schwarz at 10:03 CET on Saturday, October 31, 2026, 0.65 percent below the Xetra close of Friday, October 30. Investors should distinguish this Saturday quote from a new Xetra session, which will provide the next regular exchange benchmark.

Investors can follow the real-time quote of Eli Lilly and Co. stock for the latest off-exchange indication.

Eli Lilly and Co. stock facts

  • Company: Eli Lilly and Co.
  • ISIN: US5324571083
  • Ticker: LLY
  • Home exchange: New York Stock Exchange
  • Lang & Schwarz quote: 1,267.10 euros at 10:03 CET on October 31, 2026
  • Xetra close: 1,275.40 euros on October 30, 2026
  • Weekly change: 11.43 percent from October 23 to October 30, 2026
  • Sector: Healthcare

The S&P 500 provides the broader US equity market context for large-cap healthcare stocks: current market coverage.

More news and analyses on Eli Lilly and Co. stock.

Disclaimer...
en | US5324571083 | ELI LILLY AND CO. | boerse | 70437973 |